Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × tazemetostat × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Follicular 6 Sarcoma 3 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Inhibition, Psychological 1 Immunoblastic Lymphadenopathy 1

Interventions

Cyclophosphamide 38 Rituximab 35 Prednisone 22 Doxorubicin 21 fludarabine 15 Vincristine 15 Specimen Handling 14 Oxaliplatin 14 Magnetic Resonance Spectroscopy 14 Lenalidomide 14 Gemcitabine 14 polatuzumab vedotin 13 CT-P10 11 Etoposide 10 Biopsy 9 fludarabine phosphate 7 deltacortene 7 axicabtagene ciloleucel 7 Leukapheresis 7 Immunotherapy, Adoptive 7 venetoclax 6 prednylidene 6 glofitamab 6 pembrolizumab 5 obinutuzumab 5 ibrutinib 5 acalabrutinib 5 Prednisolone 5 tisagenlecleucel 4 pegfilgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡